Who are the key players in the and united states myasthenia gravis market?

Q: Who are the key players in the and united states myasthenia gravis market?

Some of the key players are Japan, Takeda, F.Hoffmann-La Roche, CSL Behring, Grifols S A, Alexion Pharmaceutical, Avadel Pharmaceuticals, Baxter International, Novartis, Bausch Health, Takeda Pharmaceutical Company, Others.

Global Myasthenia Gravis Market Insights and Forecast to 2028

Code: QYRE-Auto-28J3997

Report

February 2022

Pages:114

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Alexion Pharmaceutical

Avadel Pharmaceuticals

Baxter International

Novartis

Bausch Health

Takeda Pharmaceutical Company

Japan

Market Analysis and Insights: Global Myasthenia Gravis Market

The global Myasthenia Gravis market size is projected to reach US$ 2442 million by 2028, from US$ 1185 million in 2021, at a CAGR of 10.4% during 2022-2028.

Fully considering the economic change by this health crisis, Drug Treatment accounting for % of the Myasthenia Gravis global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Myasthenia Gravis market size is valued at US$ million in 2021, while the North America and Europe Myasthenia Gravis are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Myasthenia Gravis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Myasthenia Gravis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Myasthenia Gravis market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Myasthenia Gravis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Myasthenia Gravis market.

Global Myasthenia Gravis Scope and Market Size

Myasthenia Gravis market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Myasthenia Gravis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Drug Treatment

Rapid Immunotherapies

Segment by Application

Hospitals

Clinics

Other

BY COMPANY

Takeda

F. Hoffmann-La Roche

CSL Behring

Grifols

Alexion Pharmaceutical

Avadel Pharmaceuticals

Baxter International

Novartis

Bausch Health

Takeda Pharmaceutical Company

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Alexion Pharmaceutical

Avadel Pharmaceuticals

Baxter International

Novartis

Bausch Health

Takeda Pharmaceutical Company

Japan

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Myasthenia Gravis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Drug Treatment

1.2.3 Rapid Immunotherapies

1.3 Market by Application

1.3.1 Global Myasthenia Gravis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Myasthenia Gravis Market Perspective (2017-2028)

2.2 Myasthenia Gravis Growth Trends by Region

2.2.1 Myasthenia Gravis Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Myasthenia Gravis Historic Market Size by Region (2017-2022)

2.2.3 Myasthenia Gravis Forecasted Market Size by Region (2023-2028)

2.3 Myasthenia Gravis Market Dynamics

2.3.1 Myasthenia Gravis Industry Trends

2.3.2 Myasthenia Gravis Market Drivers

2.3.3 Myasthenia Gravis Market Challenges

2.3.4 Myasthenia Gravis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Myasthenia Gravis Players by Revenue

3.1.1 Global Top Myasthenia Gravis Players by Revenue (2017-2022)

3.1.2 Global Myasthenia Gravis Revenue Market Share by Players (2017-2022)

3.2 Global Myasthenia Gravis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Myasthenia Gravis Revenue

3.4 Global Myasthenia Gravis Market Concentration Ratio

3.4.1 Global Myasthenia Gravis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Revenue in 2021

3.5 Myasthenia Gravis Key Players Head office and Area Served

3.6 Key Players Myasthenia Gravis Product Solution and Service

3.7 Date of Enter into Myasthenia Gravis Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Myasthenia Gravis Breakdown Data by Type

4.1 Global Myasthenia Gravis Historic Market Size by Type (2017-2022)

4.2 Global Myasthenia Gravis Forecasted Market Size by Type (2023-2028)

5 Myasthenia Gravis Breakdown Data by Application

5.1 Global Myasthenia Gravis Historic Market Size by Application (2017-2022)

5.2 Global Myasthenia Gravis Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Myasthenia Gravis Market Size (2017-2028)

6.2 North America Myasthenia Gravis Market Size by Type

6.2.1 North America Myasthenia Gravis Market Size by Type (2017-2022)

6.2.2 North America Myasthenia Gravis Market Size by Type (2023-2028)

6.2.3 North America Myasthenia Gravis Market Share by Type (2017-2028)

6.3 North America Myasthenia Gravis Market Size by Application

6.3.1 North America Myasthenia Gravis Market Size by Application (2017-2022)

6.3.2 North America Myasthenia Gravis Market Size by Application (2023-2028)

6.3.3 North America Myasthenia Gravis Market Share by Application (2017-2028)

6.4 North America Myasthenia Gravis Market Size by Country

6.4.1 North America Myasthenia Gravis Market Size by Country (2017-2022)

6.4.2 North America Myasthenia Gravis Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Myasthenia Gravis Market Size (2017-2028)

7.2 Europe Myasthenia Gravis Market Size by Type

7.2.1 Europe Myasthenia Gravis Market Size by Type (2017-2022)

7.2.2 Europe Myasthenia Gravis Market Size by Type (2023-2028)

7.2.3 Europe Myasthenia Gravis Market Share by Type (2017-2028)

7.3 Europe Myasthenia Gravis Market Size by Application

7.3.1 Europe Myasthenia Gravis Market Size by Application (2017-2022)

7.3.2 Europe Myasthenia Gravis Market Size by Application (2023-2028)

7.3.3 Europe Myasthenia Gravis Market Share by Application (2017-2028)

7.4 Europe Myasthenia Gravis Market Size by Country

7.4.1 Europe Myasthenia Gravis Market Size by Country (2017-2022)

7.4.2 Europe Myasthenia Gravis Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Myasthenia Gravis Market Size (2017-2028)

8.2 Asia-Pacific Myasthenia Gravis Market Size by Type

8.2.1 Asia-Pacific Myasthenia Gravis Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Myasthenia Gravis Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Myasthenia Gravis Market Share by Type (2017-2028)

8.3 Asia-Pacific Myasthenia Gravis Market Size by Application

8.3.1 Asia-Pacific Myasthenia Gravis Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Myasthenia Gravis Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Myasthenia Gravis Market Share by Application (2017-2028)

8.4 Asia-Pacific Myasthenia Gravis Market Size by Region

8.4.1 Asia-Pacific Myasthenia Gravis Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Myasthenia Gravis Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Myasthenia Gravis Market Size (2017-2028)

9.2 Latin America Myasthenia Gravis Market Size by Type

9.2.1 Latin America Myasthenia Gravis Market Size by Type (2017-2022)

9.2.2 Latin America Myasthenia Gravis Market Size by Type (2023-2028)

9.2.3 Latin America Myasthenia Gravis Market Share by Type (2017-2028)

9.3 Latin America Myasthenia Gravis Market Size by Application

9.3.1 Latin America Myasthenia Gravis Market Size by Application (2017-2022)

9.3.2 Latin America Myasthenia Gravis Market Size by Application (2023-2028)

9.3.3 Latin America Myasthenia Gravis Market Share by Application (2017-2028)

9.4 Latin America Myasthenia Gravis Market Size by Country

9.4.1 Latin America Myasthenia Gravis Market Size by Country (2017-2022)

9.4.2 Latin America Myasthenia Gravis Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Myasthenia Gravis Market Size (2017-2028)

10.2 Middle East & Africa Myasthenia Gravis Market Size by Type

10.2.1 Middle East & Africa Myasthenia Gravis Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Myasthenia Gravis Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Myasthenia Gravis Market Share by Type (2017-2028)

10.3 Middle East & Africa Myasthenia Gravis Market Size by Application

10.3.1 Middle East & Africa Myasthenia Gravis Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Myasthenia Gravis Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Myasthenia Gravis Market Share by Application (2017-2028)

10.4 Middle East & Africa Myasthenia Gravis Market Size by Country

10.4.1 Middle East & Africa Myasthenia Gravis Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Myasthenia Gravis Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Details

11.1.2 Takeda Business Overview

11.1.3 Takeda Myasthenia Gravis Introduction

11.1.4 Takeda Revenue in Myasthenia Gravis Business (2017-2022)

11.1.5 Takeda Recent Developments

11.2 F. Hoffmann-La Roche

11.2.1 F. Hoffmann-La Roche Company Details

11.2.2 F. Hoffmann-La Roche Business Overview

11.2.3 F. Hoffmann-La Roche Myasthenia Gravis Introduction

11.2.4 F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2017-2022)

11.2.5 F. Hoffmann-La Roche Recent Developments

11.3 CSL Behring

11.3.1 CSL Behring Company Details

11.3.2 CSL Behring Business Overview

11.3.3 CSL Behring Myasthenia Gravis Introduction

11.3.4 CSL Behring Revenue in Myasthenia Gravis Business (2017-2022)

11.3.5 CSL Behring Recent Developments

11.4 Grifols

11.4.1 Grifols Company Details

11.4.2 Grifols Business Overview

11.4.3 Grifols Myasthenia Gravis Introduction

11.4.4 Grifols Revenue in Myasthenia Gravis Business (2017-2022)

11.4.5 Grifols Recent Developments

11.5 Alexion Pharmaceutical

11.5.1 Alexion Pharmaceutical Company Details

11.5.2 Alexion Pharmaceutical Business Overview

11.5.3 Alexion Pharmaceutical Myasthenia Gravis Introduction

11.5.4 Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2017-2022)

11.5.5 Alexion Pharmaceutical Recent Developments

11.6 Avadel Pharmaceuticals

11.6.1 Avadel Pharmaceuticals Company Details

11.6.2 Avadel Pharmaceuticals Business Overview

11.6.3 Avadel Pharmaceuticals Myasthenia Gravis Introduction

11.6.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2017-2022)

11.6.5 Avadel Pharmaceuticals Recent Developments

11.7 Baxter International

11.7.1 Baxter International Company Details

11.7.2 Baxter International Business Overview

11.7.3 Baxter International Myasthenia Gravis Introduction

11.7.4 Baxter International Revenue in Myasthenia Gravis Business (2017-2022)

11.7.5 Baxter International Recent Developments

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Myasthenia Gravis Introduction

11.8.4 Novartis Revenue in Myasthenia Gravis Business (2017-2022)

11.8.5 Novartis Recent Developments

11.9 Bausch Health

11.9.1 Bausch Health Company Details

11.9.2 Bausch Health Business Overview

11.9.3 Bausch Health Myasthenia Gravis Introduction

11.9.4 Bausch Health Revenue in Myasthenia Gravis Business (2017-2022)

11.9.5 Bausch Health Recent Developments

11.10 Takeda Pharmaceutical Company

11.10.1 Takeda Pharmaceutical Company Company Details

11.10.2 Takeda Pharmaceutical Company Business Overview

11.10.3 Takeda Pharmaceutical Company Myasthenia Gravis Introduction

11.10.4 Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2017-2022)

11.10.5 Takeda Pharmaceutical Company Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alexion Pharmaceutical

Avadel Pharmaceuticals

Baxter International

Novartis

Bausch Health

Takeda Pharmaceutical Company

Japan

List of Tables

Table 1. Global Myasthenia Gravis Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Drug Treatment

Table 3. Key Players of Rapid Immunotherapies

Table 4. Global Myasthenia Gravis Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 5. Global Myasthenia Gravis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global Myasthenia Gravis Market Size by Region (2017-2022) & (US$ Million)

Table 7. Global Myasthenia Gravis Market Share by Region (2017-2022)

Table 8. Global Myasthenia Gravis Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 9. Global Myasthenia Gravis Market Share by Region (2023-2028)

Table 10. Myasthenia Gravis Market Trends

Table 11. Myasthenia Gravis Market Drivers

Table 12. Myasthenia Gravis Market Challenges

Table 13. Myasthenia Gravis Market Restraints

Table 14. Global Myasthenia Gravis Revenue by Players (2017-2022) & (US$ Million)

Table 15. Global Myasthenia Gravis Revenue Share by Players (2017-2022)

Table 16. Global Top Myasthenia Gravis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2021)

Table 17. Ranking of Global Top Myasthenia Gravis Companies by Revenue (US$ Million) in 2021

Table 18. Global 5 Largest Players Market Share by Myasthenia Gravis Revenue (CR5 and HHI) & (2017-2022)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Myasthenia Gravis Product Solution and Service

Table 21. Date of Enter into Myasthenia Gravis Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Myasthenia Gravis Market Size by Type (2017-2022) & (US$ Million)

Table 24. Global Myasthenia Gravis Revenue Market Share by Type (2017-2022)

Table 25. Global Myasthenia Gravis Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 26. Global Myasthenia Gravis Revenue Market Share by Type (2023-2028)

Table 27. Global Myasthenia Gravis Market Size by Application (2017-2022) & (US$ Million)

Table 28. Global Myasthenia Gravis Revenue Share by Application (2017-2022)

Table 29. Global Myasthenia Gravis Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 30. Global Myasthenia Gravis Revenue Share by Application (2023-2028)

Table 31. North America Myasthenia Gravis Market Size by Type (2017-2022) & (US$ Million)

Table 32. North America Myasthenia Gravis Market Size by Type (2023-2028) & (US$ Million)

Table 33. North America Myasthenia Gravis Market Size by Application (2017-2022) & (US$ Million)

Table 34. North America Myasthenia Gravis Market Size by Application (2023-2028) & (US$ Million)

Table 35. North America Myasthenia Gravis Market Size by Country (2017-2022) & (US$ Million)

Table 36. North America Myasthenia Gravis Market Size by Country (2023-2028) & (US$ Million)

Table 37. Europe Myasthenia Gravis Market Size by Type (2017-2022) & (US$ Million)

Table 38. Europe Myasthenia Gravis Market Size by Type (2023-2028) & (US$ Million)

Table 39. Europe Myasthenia Gravis Market Size by Application (2017-2022) & (US$ Million)

Table 40. Europe Myasthenia Gravis Market Size by Application (2023-2028) & (US$ Million)

Table 41. Europe Myasthenia Gravis Market Size by Country (2017-2022) & (US$ Million)

Table 42. Europe Myasthenia Gravis Market Size by Country (2023-2028) & (US$ Million)

Table 43. Asia Pacific Myasthenia Gravis Market Size by Type (2017-2022) & (US$ Million)

Table 44. Asia Pacific Myasthenia Gravis Market Size by Type (2023-2028) & (US$ Million)

Table 45. Asia Pacific Myasthenia Gravis Market Size by Application (2017-2022) & (US$ Million)

Table 46. Asia Pacific Myasthenia Gravis Market Size by Application (2023-2028) & (US$ Million)

Table 47. Asia Pacific Myasthenia Gravis Market Size by Region (2017-2022) & (US$ Million)

Table 48. Asia Pacific Myasthenia Gravis Market Size by Region (2023-2028) & (US$ Million)

Table 49. Latin America Myasthenia Gravis Market Size by Type (2017-2022) & (US$ Million)

Table 50. Latin America Myasthenia Gravis Market Size by Type (2023-2028) & (US$ Million)

Table 51. Latin America Myasthenia Gravis Market Size by Application (2017-2022) & (US$ Million)

Table 52. Latin America Myasthenia Gravis Market Size by Application (2023-2028) & (US$ Million)

Table 53. Latin America Myasthenia Gravis Market Size by Country (2017-2022) & (US$ Million)

Table 54. Latin America Myasthenia Gravis Market Size by Country (2023-2028) & (US$ Million)

Table 55. Middle East and Africa Myasthenia Gravis Market Size by Type (2017-2022) & (US$ Million)

Table 56. Middle East and Africa Myasthenia Gravis Market Size by Type (2023-2028) & (US$ Million)

Table 57. Middle East and Africa Myasthenia Gravis Market Size by Application (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Myasthenia Gravis Market Size by Application (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Myasthenia Gravis Market Size by Country (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Myasthenia Gravis Market Size by Country (2023-2028) & (US$ Million)

Table 61. Takeda Company Details

Table 62. Takeda Business Overview

Table 63. Takeda Myasthenia Gravis Product

Table 64. Takeda Revenue in Myasthenia Gravis Business (2017-2022) & (US$ Million)

Table 65. Takeda Recent Developments

Table 66. F. Hoffmann-La Roche Company Details

Table 67. F. Hoffmann-La Roche Business Overview

Table 68. F. Hoffmann-La Roche Myasthenia Gravis Product

Table 69. F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2017-2022) & (US$ Million)

Table 70. F. Hoffmann-La Roche Recent Developments

Table 71. CSL Behring Company Details

Table 72. CSL Behring Business Overview

Table 73. CSL Behring Myasthenia Gravis Product

Table 74. CSL Behring Revenue in Myasthenia Gravis Business (2017-2022) & (US$ Million)

Table 75. CSL Behring Recent Developments

Table 76. Grifols Company Details

Table 77. Grifols Business Overview

Table 78. Grifols Myasthenia Gravis Product

Table 79. Grifols Revenue in Myasthenia Gravis Business (2017-2022) & (US$ Million)

Table 80. Grifols Recent Developments

Table 81. Alexion Pharmaceutical Company Details

Table 82. Alexion Pharmaceutical Business Overview

Table 83. Alexion Pharmaceutical Myasthenia Gravis Product

Table 84. Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2017-2022) & (US$ Million)

Table 85. Alexion Pharmaceutical Recent Developments

Table 86. Avadel Pharmaceuticals Company Details

Table 87. Avadel Pharmaceuticals Business Overview

Table 88. Avadel Pharmaceuticals Myasthenia Gravis Product

Table 89. Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2017-2022) & (US$ Million)

Table 90. Avadel Pharmaceuticals Recent Developments

Table 91. Baxter International Company Details

Table 92. Baxter International Business Overview

Table 93. Baxter International Myasthenia Gravis Product

Table 94. Baxter International Revenue in Myasthenia Gravis Business (2017-2022) & (US$ Million)

Table 95. Baxter International Recent Developments

Table 96. Novartis Company Details

Table 97. Novartis Business Overview

Table 98. Novartis Myasthenia Gravis Product

Table 99. Novartis Revenue in Myasthenia Gravis Business (2017-2022) & (US$ Million)

Table 100. Novartis Recent Developments

Table 101. Bausch Health Company Details

Table 102. Bausch Health Business Overview

Table 103. Bausch Health Myasthenia Gravis Product

Table 104. Bausch Health Revenue in Myasthenia Gravis Business (2017-2022) & (US$ Million)

Table 105. Bausch Health Recent Developments

Table 106. Takeda Pharmaceutical Company Company Details

Table 107. Takeda Pharmaceutical Company Business Overview

Table 108. Takeda Pharmaceutical Company Myasthenia Gravis Product

Table 109. Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2017-2022) & (US$ Million)

Table 110. Takeda Pharmaceutical Company Recent Developments

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Myasthenia Gravis Market Share by Type: 2021 VS 2028

Figure 2. Drug Treatment Features

Figure 3. Rapid Immunotherapies Features

Figure 4. Global Myasthenia Gravis Market Share by Application: 2021 VS 2028

Figure 5. Hospitals Case Studies

Figure 6. Clinics Case Studies

Figure 7. Other Case Studies

Figure 8. Myasthenia Gravis Report Years Considered

Figure 9. Global Myasthenia Gravis Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 10. Global Myasthenia Gravis Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Myasthenia Gravis Market Share by Region: 2021 VS 2028

Figure 12. Global Myasthenia Gravis Market Share by Players in 2021

Figure 13. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2021)

Figure 14. The Top 10 and 5 Players Market Share by Myasthenia Gravis Revenue in 2021

Figure 15. North America Myasthenia Gravis Market Size YoY (2017-2028) & (US$ Million)

Figure 16. North America Myasthenia Gravis Market Size Market Share by Type (2017-2028)

Figure 17. North America Myasthenia Gravis Market Size Market Share by Application (2017-2028)

Figure 18. North America Myasthenia Gravis Market Size Share by Country (2017-2028)

Figure 19. United States Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 20. Canada Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Europe Myasthenia Gravis Market Size YoY (2017-2028) & (US$ Million)

Figure 22. Europe Myasthenia Gravis Market Size Market Share by Type (2017-2028)

Figure 23. Europe Myasthenia Gravis Market Size Market Share by Application (2017-2028)

Figure 24. Europe Myasthenia Gravis Market Size Share by Country (2017-2028)

Figure 25. Germany Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. France Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. U.K. Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. Italy Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Russia Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Nordic Countries Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Asia-Pacific Myasthenia Gravis Market Size YoY (2017-2028) & (US$ Million)

Figure 32. Asia Pacific Myasthenia Gravis Market Size Market Share by Type (2017-2028)

Figure 33. Asia Pacific Myasthenia Gravis Market Size Market Share by Application (2017-2028)

Figure 34. Asia Pacific Myasthenia Gravis Market Size Share by Region (2017-2028)

Figure 35. China Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. Japan Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. South Korea Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Southeast Asia Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. India Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Australia Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 41. Latin America Myasthenia Gravis Market Size YoY (2017-2028) & (US$ Million)

Figure 42. Latin America Myasthenia Gravis Market Size Market Share by Type (2017-2028)

Figure 43. Latin America Myasthenia Gravis Market Size Market Share by Application (2017-2028)

Figure 44. Latin America Myasthenia Gravis Market Size Share by Country (2017-2028)

Figure 45. Mexico Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 46. Brazil Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 47. Middle East & Africa Myasthenia Gravis Market Size YoY (2017-2028) & (US$ Million)

Figure 48. Middle East and Africa Myasthenia Gravis Market Size Market Share by Type (2017-2028)

Figure 49. Middle East and Africa Myasthenia Gravis Market Size Market Share by Application (2017-2028)

Figure 50. Middle East and Africa Myasthenia Gravis Market Size Share by Country (2017-2028)

Figure 51. Turkey Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 52. Saudi Arabia Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 53. UAE Myasthenia Gravis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. Takeda Revenue Growth Rate in Myasthenia Gravis Business (2017-2022)

Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in Myasthenia Gravis Business (2017-2022)

Figure 56. CSL Behring Revenue Growth Rate in Myasthenia Gravis Business (2017-2022)

Figure 57. Grifols Revenue Growth Rate in Myasthenia Gravis Business (2017-2022)

Figure 58. Alexion Pharmaceutical Revenue Growth Rate in Myasthenia Gravis Business (2017-2022)

Figure 59. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Business (2017-2022)

Figure 60. Baxter International Revenue Growth Rate in Myasthenia Gravis Business (2017-2022)

Figure 61. Novartis Revenue Growth Rate in Myasthenia Gravis Business (2017-2022)

Figure 62. Bausch Health Revenue Growth Rate in Myasthenia Gravis Business (2017-2022)

Figure 63. Takeda Pharmaceutical Company Revenue Growth Rate in Myasthenia Gravis Business (2017-2022)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Myasthenia Gravis Market Insights and Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-28J3997

Global Myasthenia Gravis Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25F541

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-13V842

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-6O906

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-30I649

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions